NCT01392534 - Effects of Telmisartan/Hydrochlorothiazide Treatment in Hypertensive Patients Under Real-life Setting | Biotech Hunter

Enrollment

1,586

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Primary Hypertension

Interventions

DRUG

Telmisartan/hydrochlorothiazide (Pritor Plus, BAY98-7103)

Patients treated with telmisartan/hydrochlorothiazide tablets under the real-life setting. Dosing regimen customised to the needs of each participating patient according to the investigators assessment

Trial Locations (1)

Unknown

Many Locations